Drugs / BCG
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy1 trial | ||||||
| Phase 1/2 | NCT02933281 Comparator | May 2018 → Sep 2021 | tuberculosis | International AIDS Vaccine Initiative | Completed | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BCG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT02933281 ↗ |
| Modality | Vaccine | “previous BCG vaccination” NCT02933281 ↗ |
| Route | Other | “administered intradermally on Study Day 0” NCT02933281 ↗ |